Citing new evidence from the ever-growing amount of COVID-19 data, the Centers for Disease Control and Prevention (CDC) have revised their earlier recommendations, expanding the list of those at the highest risk during the coronavirus pandemic.
The coronavirus pandemic has already exacted an incalculable toll, but we likely won’t fully understand its lasting effects on our way of life for years to come. Already it is changing the way patients look at and approach their healthcare.
Originally announced in mid-May, Operation Warp Speed is the name given to the US federal government’s accelerated COVID-19 vaccine development initiative. It is a partnership between the government, multiple agencies, and the private companies working to find a vaccine.
This week the U.S. Food and Drug Administration (FDA) updated recommendations and revoked existing emergency use authorizations concerning chloroquine, hydroxychloroquine, and other potential COVID-19 drugs.
In a recent decision, the US Food and Drug Administration (FDA) has put forward new guidelines on what types of respirators are safe for medical professionals to decontaminate and reuse while interacting with COVID-19 patients.